Product Details

Verac-P Suspension combines a non-steroidal anti-inflammatory drug with a centrally acting analgesic and antipyretic for the effective management of pain, fever, and inflammation. Specifically, each 5ml delivers Aceclofenac IP 50mg together with Paracetamol IP 125mg. As a result, it offers a convenient liquid formulation for patients who have difficulty swallowing tablets or capsules.

The suspension combines:

• Aceclofenac IP (50mg per 5ml) – A non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes. Consequently, it blocks prostaglandin synthesis, delivering effective analgesic and anti-inflammatory action.
• Paracetamol IP (125mg per 5ml) – A centrally acting analgesic and antipyretic that inhibits prostaglandin synthesis in the central nervous system. As a result, it complements Aceclofenac’s action by reducing fever and enhancing overall pain relief.

Physicians prescribe Verac-P for the short-term relief of mild to moderate pain and fever associated with musculoskeletal conditions, minor injuries, and inflammatory conditions. In addition, its oral suspension format supports easy administration for patients, including children and those with swallowing difficulties, when dosed appropriately for age and weight. Because of this profile, Verac-P suits general practice, paediatric, and orthopaedic settings managing pain and fever.

Key Features:

• Overall, this formulation guarantees pharmaceutical-grade purity across both actives
• Additionally, the oral suspension format supports easy administration and flexible dosing
• Furthermore, each 5ml delivers precise, validated dosage accuracy at 50mg + 125mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, light-protected bottle packaging preserves suspension stability
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies